MHRA Guidance on Centrally Authorised Products (CAPs) Bridging Mechanism MHRA Guidance on Centrally Authorised Products (CAPs) Bridging Mechanism MHRA has published guidance on Centrally Authorised Products (CAPs) Bridging Mechanism. MHRA Guidance on Centrally Authorised Products (CAPs) Bridging Mechanism
MHRA Publishes Marketing Authorisations Granted 15 May to 31 May 2023 MHRA Publishes Marketing Authorisations Granted 15 May to 31 May 2023 MHRA granted two OTC licences during 15-31 May 2023. MHRA Publishes Marketing Authorisations Granted 15 May to 31 May 2023
PAGB/AESGP EU Pharmaceutical Law Revision Webinar – Register Now! PAGB/AESGP Webinar – EU Pharmaceutical Law Revision As part of the EU pharmaceuticals strategy, and drawing lessons from the Covid-19... PAGB/AESGP EU Pharmaceutical Law Revision Webinar – Register Now!
CMDh Report from May 2023 Meeting CMDh Report from May 2023 Meeting The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh Report from May 2023 Meeting
MHRA Updates Guidance on Submission of Nitrosamine Risk Evaluation, Risk Assessment and Confirmatory Testing MHRA Updates Guidance on Submission of Nitrosamine Risk Evaluation, Risk Assessment and Confirmatory Testing MHRA has updated its g... MHRA Updates Guidance on Submission of Nitrosamine Risk Evaluation, Risk Assessment and Confirmatory Testing
EMA/HMA Good Practice Guide for Industry on Prevention and Management of Shortages EMA/HMA Good Practice Guide for Industry on Prevention and Management of Shortages The European Medicines Agency (EMA) and... EMA/HMA Good Practice Guide for Industry on Prevention and Management of Shortages
MHRA Publishes Marketing Authorisations Granted 1 May to 14 May 2023 MHRA Publishes Marketing Authorisations Granted 1 May to 14 May MHRA granted one OTC licence during 1-14 May 2023. Details... MHRA Publishes Marketing Authorisations Granted 1 May to 14 May 2023
Medicines Legislation Adopted by the European Parliament in line with the Windsor Framework Medicines Legislation Adopted by the European Parliament in line with the Windsor Framework The European Parliament agreed... Medicines Legislation Adopted by the European Parliament in line with the Windsor Framework
Clinical Trials Information System (CTIS) Transparency Rules Clinical Trials Information System (CTIS) Transparency Rules A public consultation on the Clinical Trials Information System (CTIS) transparency rules has... Clinical Trials Information System (CTIS) Transparency Rules
SCHEER Call for Information for Updating Guidelines on Presence of Phthalates in Certain Medical Devices SCHEER Call for Information for Updating Guidelines on Presence of Phthalates in Certain Medical Devices The Scientific Committee on Health,... SCHEER Call for Information for Updating Guidelines on Presence of Phthalates in Certain Medical Devices
EMA HMPC Launches Calls for Submission of Scientific Data EMA HMPC Launches Calls for Submission of Scientific Data The European Medicines Agency’s (EMA) Committee on Herbal Medicinal Products (HMPC)... EMA HMPC Launches Calls for Submission of Scientific Data
MHRA Board Meeting – 16 May 2023 MHRA Board Meeting – 16 May 2023 The MHRA Board will meet in public on Tuesday 16 May 2023 from... MHRA Board Meeting – 16 May 2023
